1Hermanussen M, Garciaap, Sunder M, et al. Obesity, voraci- ty,and short stature:the impact of glutamate on the regula- tionof appetite[ J]. Eur J Clin Nutr,2006 ,60 :25 -31.
7John FB, Morrison SS, Rajan S, et al. Sensory and autonomic nerve changes in the monosodium glutamate -treated rat:a model of typell diabetes [ J ]. Exp Physio1,2007,93 (2) : 213 - 222.
4Advance Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008, 358: 2560-2572.
5Colwell J A. Aspirin therapy in diabetes. Diabetes Care, 1997, 20: 1767-1771.
6Boden G.Role of fatty acids in pathogenesis of insulin resistance and NIDDM[J].Diabetes,1997;45:3-10.
7Shepherd PR,Kahn BB.Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus[J].N Eng1 J Med,1999;341:248-57.
8葛可佑.90年代中国人群的膳食与营养状况[M].北京:人民卫生出版社,1995.424
9Dawson R Jr,Annau Z. A behavioral assessment of arcuate nucleus damage after a single injection of monosodium glutamate. Neurobehav Toxocol Teratol,1983,5(4):399-406
10Bunyan J, Murrell EA,Shah PP.The induction of obesity in rodents by means of monosodium glutamate.Br J Nutr, 1976,35(1):25-39
